Silvano Spinelli

Silvano Spinelli is a Venture Partner at Sofinnova Partners, Chairman of the Italian biotech accelerator BiovelocITA, and Co-Founder and Chairman of Enthera Pharmaceuticals. Prior to his current investment roles, he served as the Founder and Chief Executive Officer of Novuspharma, leading the oncology company to a €160 million initial public offering in 2000 before its acquisition by Cell Therapeutics in 2003. He subsequently founded and served as President and CEO of EOS from 2006 until 2013, culminating in the company's $470 million acquisition by Clovis Oncology. Earlier in his career, Spinelli worked as the Head of Research and Development at Boehringer Mannheim Italia and earned a degree in organic chemistry from the University of Pisa. Drawing on over two decades of sector experience, he currently focuses on financing early-stage bioscience ventures and accelerating oncology-focused therapeutics startups.